Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Gastrointestinal Stromal Tumor Market?
The gastrointestinal stromal tumor market has experienced substantial expansion in recent years. This market is projected to grow from $1.28 billion in 2024 to $1.36 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.7%. The historical growth can be ascribed to elements like heightened awareness and early diagnosis, the advent of targeted therapies, advancements in surgical techniques, the evolution of personalized medicine, and enhancements in supportive care.
The market for gastrointestinal stromal tumors is projected to experience substantial expansion over the upcoming years. This market is set to reach a valuation of $1.82 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.5%. The anticipated growth during this period stems from ongoing advancements in research and drug creation, a surge in patient-focused healthcare approaches, the incorporation of precision medicine into clinical settings, improved availability of targeted treatments, and enhanced genomic profiling capacities. Key trends shaping the forecast horizon encompass increased cooperation in research and development, technological progress in diagnostics, joint research initiatives and clinical trials, a heightened emphasis on early diagnosis and detection, and the investigation of combination therapy options.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13248&type=smp
What Are The Key Drivers Of Growth In The Gastrointestinal Stromal Tumor Market?
The escalating incidence of stomach cancer is anticipated to propel the future growth of the gastrointestinal stromal tumor market. Stomach cancer is defined by the unrestrained growth and multiplication of malignant cells within the stomach’s inner lining. While gastrointestinal stromal tumors (GISTs) can develop in the stomach, they are distinct from stomach cancer. It has been observed that patients with GISTs face an elevated risk of developing additional cancers, including small bowel adenocarcinoma, particularly when two separate tumors merge. As an illustration, the American Cancer Society, a US-based professional organization, stated in January 2024 that approximately 26,890 new cases of stomach cancer and 10,880 deaths are projected in the U.S. for 2024, representing 1.5% of all new cancer diagnoses. Therefore, the increasing occurrence of stomach cancer is fueling the expansion of the gastrointestinal stromal tumor market.
How Is The Gastrointestinal Stromal Tumor Market Classified Into Different Segments?
The gastrointestinal stromal tumormarket covered in this report is segmented –
1) By Treatment Type: Chemotherapy; Targeted Therapy; Other Treatment Types
2) By Indication: Stomach; Small Intestine; Others Indications
3) By End-User: Hospitals; Clinics; Specialized Cancer Treatment Centers; Other End-Users
Subsegments:
1) By Chemotherapy: Traditional Chemotherapy Agents; Combination Chemotherapy Regimens
2) By Targeted Therapy: Tyrosine Kinase Inhibitors; Other Targeted Agents
3) By Other Treatment Types: Surgery; Radiation Therapy; Clinical Trials For Novel Therapies
Which Market Trends Are Creating New Opportunities In The Gastrointestinal Stromal Tumor Industry?
Major companies engaged in the gastrointestinal stromal tumor market are developing new medications such as QINLOCK (Ripretinib) to serve larger client bases, generate more sales, and enhance revenue. QINLOCK (Ripretinib) is a prescribed drug utilized for treating advanced gastrointestinal stromal tumor (GIST). For instance, in January 2024, according to the US Food and Drug Administration (FDA), a federal agency based in the US, the CDER novel drug approvals stood at 37 in 2022, increasing to 55 drugs in 2023. CDER reported that 20 out of the 55 novel drugs (36%) approved in 2023 were first-in-class.
Who Are The Core Companies Influencing The Gastrointestinal Stromal Tumor Market Landscape?
Major companies operating in the gastrointestinal stromal tumor market report are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Advenchen Laboratories LLC, Arog Pharmaceuticals Inc., AB Sciences S.A.
Download The Full Report For Exclusive Market Findings:
How Is Gastrointestinal Stromal Tumor Market Demand Varying Across Different Regions?
North America was the largest region in the gastrointestinal stromal tumor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Gastrointestinal Stromal Tumor Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13248&type=smp
Browse Through More Reports Similar to the Global Gastrointestinal Stromal Tumor Market 2025, By The Business Research Company
Tumor Ablation Therapy Devices Global Market Report 2025
Tumor Embolization Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Cancer Tumor Profiling Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model